Ships from our US warehouse — fast domestic shipping
Shipping details
Home/Products/Survodutide
Survodutide — existing catalog illustration
Existing catalog illustration. A pictured label is not a batch result and may differ from the selected specification.

Modified peptide / Material & research guide

Survodutide

Survodutide, also referenced as BI 456906, is investigated as a dual GLP-1 and glucagon receptor agonist.

Catalog specification — select for your inquiry

Selected: 10 mg × 10 vials

Nominal catalog options, not a live availability guarantee. Final supply is confirmed in the written quotation.

Material profile

About the material

Survodutide, also referenced as BI 456906, is investigated as a dual GLP-1 and glucagon receptor agonist.

For Survodutide, the useful starting point is the material identity—not the broad research category. Compare the complete name and supplied form with the reference used by your laboratory.

The key distinction
Use the full compound name and research identifier when specifying the requested material. Confirm modification, counter-ion and analytical identity for the lot.

Scientific context

Research context

The GLP-1/glucagon research combination differs from the GIP/GLP-1 combination associated with tirzepatide. Receptor names matter when comparing literature.

01

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis.

The New England journal of medicine · 2024 · PMID 38847460

Read the named material, experimental model, controls and limitations in the original paper. This source is scientific background, not a certificate for the offered lot.

Read the primary publication ↗
02

Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial.

The lancet. Diabetes & endocrinology · 2024 · PMID 38330987

Read the named material, experimental model, controls and limitations in the original paper. This source is scientific background, not a certificate for the offered lot.

Read the primary publication ↗

For laboratory research use only. Not for human or veterinary use, diagnosis or therapeutic application. No administration or dosing protocol is provided.

Catalog & quotation

Specifications

Catalog materialSurvodutide
Material classModified peptide
Listed options10 mg × 10 vials
Identity / supplied formUse the full compound name and research identifier when specifying the requested material. Confirm modification, counter-ion and analytical identity for the lot.
Identity, purity and contentRequest the method, acceptance specification and lot-specific results. Chromatographic purity and net material content are separate measurements.
Storage / stabilityFollow the written instructions for the actual material and batch. No universal 24-month shelf life or solution stability is assumed.
Catalog options are inquiry specifications, not a live stock feed. The final quotation must confirm the material, amount, packaging and document scope.

Evidence for the offered material

Documents

Confirm document availability for the actual material and lot. A catalog purity target or packaging label is not a released batch result.

Identity

Use the full compound name and research identifier when specifying the requested material. Confirm modification, counter-ion and analytical identity for the lot.

Analytical scope

Ask which tests and underlying files are available, what each result measures and which batch it covers. Do not infer a test result from an image or badge.

Order match

Match product name, selected specification, lot reference and packaging to the quotation. Ask about any difference before confirming supply.

Before you inquire

Questions

How does the reference identity differ from Tirz?

Use the full compound name and research identifier when specifying the requested material. Confirm modification, counter-ion and analytical identity for the lot.

What should my Survodutide inquiry include?

Include the exact material name, the catalog option or required specification, quantity, destination and any documents needed before quotation. Keep nominal amount per container separate from the number of containers.

Does the catalog image confirm the selected specification?

No. It is a catalog illustration. The image may show one variant while the selector lists other options. Use the written quotation and matching batch documents to confirm supply.

Does a paper or an existing report validate every future batch?

No. A paper describes its studied material and model. An analytical report describes a named sample. Confirm the connection between any report and the lot offered for your order.

Catalog content reviewed 26 September 2026. Listed options are from this site's product records. Scientific sources, where shown, describe research context, not batch certification.

Build your Survodutide inquiry.

Include the material, amount and evidence your laboratory needs to review.

Prepare an inquiry